Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 292 results for "lupin"

Lupin Q1 PAT seen up 33.4% at Rs 535.1 cr: P Lilladher

Sales are expected to increase by 5.3 percent Q-o-Q (up 32.7 percent Y-o-Y) to Rs 3213.4 according to Prabhudas Lilladher. Money Control, 8 minutes ago
Lupin posts excellent Q4 FY14 numbers Money Control, 2 months ago
Lupin surprises analysts with strong Q4 show Money Control, 2 months ago

312 images for lupin, 6 days ago
South Florida Sun-Sentinel, 1 week ago
Fidelity Brokerage Services LLC, 1 week ago
Pinedale Online, 4 days ago
Minnesota Monthly, 5 days ago
Money Today, 1 week ago
Yahoo! Finance, 1 week ago
Reuters India, 1 week ago, 1 week ago
West Australian, 1 week ago
Business Standard

Lupin Q1 profit may rise 26% to Rs 505 cr on strong revenue

Operating profit (EBITDA) is expected to jump 37.4 percent to Rs 810 crore and margin may expand 260 basis points to 26.4 percent compared to the year-ago period.
 Money Control10 minutes ago Lupin hikes R&D; spend to support US facility  DNA2 months ago Lupin net profit rises 329.58% in the March 2014 quarter  Business Standard2 months ago Lupin Q4 Cons net profit at Rs553 crore  India Infoline2 months ago

Aurobindo, Lupin being sued on generics plans

Multinational drugmakers Pfizer and Forest Laboratories have filed lawsuits against Indian generic company Aurobindo, as it wants to manufacture copycat versions of drugs of which they have patents. Not just Aurobindo, Lupin too is in a similar ...
 Financial Chronicle1 day ago Lupin eyes popular GSK brands  The Telegraph1 week ago India Generic Giant Lupin to Bid on GSK's Mature Drugs  Pharmaceutical Manufacturing Magazine6 days ago GSK slimming further as sales fall on Advair competition  FiercePharma6 days ago
Business Line

Lupin CFO Ramesh Swaminathan on growth strategy and new geographies it plans to enter

Lupin is the second-largest pharma company in the country by market capitalisation behind Sun Pharma. It is dominant in the anti-TB and cephalosporin segment but is also a significant player in the cardiovascular, diabetology, asthma, paediatrics ...
 VC Circle1 day ago Lupin Pharmaceuticals, Inc. committed to quality, innovation  Drugtopics.com1 week ago Lupin Sued by Bausch + Lomb and Senju Over Generic Prolensa  FDA News3 weeks ago Lupin plans acquisitions in India, Japan  DNA1 month ago

Pharma shares trade firm

Pharma stocks Sun Pharma Industries and Lupin made rapid strides in the second half of the session on the NSE on Friday. At the close Sun Pharma was the top gainer. It was quoting at ₹782.20, up 4.54 per cent on yesterday's close at ₹748.20. ...
 Hindu Business Line4 days ago Pharma shares in demand; Healthcare index hits new high  Business Standard4 days ago Pharma shares in demand; Aurobindo surges 5%  INooz2 weeks ago Lupin, Wockhardt, Glenmark to get astro support: Gupta  Money Control2 months ago

Sun Pharma, Lupin perk up

Hindustan Unilever was broadly firm in Friday morning trade on the bourses. It was the top gainer on both the BSE and NSE. At 11.15 am it held gains of 2.50 per cent on the NSE, quoting at ₹659 as against ₹642.90 at close yesterday. Sun Pharma ...
 Hindu Business Line4 days ago Lupin leads the pack on NSE, up 1.8%  Business Line2 weeks ago Sun Pharma, Dr Reddy's rally on strong gross sales in June  Money Control2 weeks ago Lupin, Dr Reddys Lab top picks in pharma space: ICICIdirect  Money Control3 weeks ago

Axis Bank, Cairn India, Lupin in Focus Today

The Nifty is likely to open above 7,800 marks on Wednesday as indicated by futures trade on Singapore Stock Exchange. Both foreign and domestic investors remained net buyers of Indian equities on Tuesday. FIIs bought shares worth Rs 412 crore and ...
 NDTV Profit1 week ago Here are top 10 stocks to focus on July 23  Money Control1 week ago
Business Standard

Over 250 stocks hits 52-week highs; Tata Motors, Sun Pharma, Lupin hit record highs

Tata Motors, Sun Pharma, Lupin, Asian Paints, Atul Limited, Page Industries and Alembic Pharma from BSE-500 index hits record high.
 Business Standard1 week ago Healthcare Index hits all-time high  Business Standard1 month ago Weekly Wrap : Sensex, Nifty post new all-time highs  Sify3 days ago Indian shares regain poise as economic turnaround strengthens  Gulf News1 week ago

India to outperform peers; bet on HDFC Bk, TCS, Lupin: FC

With key event the Union Budget out of market’s way, Jeff Chowdhry, head of emerging market equities, FC Investments sees big-sized global funds to drive the Indian stock market from hereon.
 Money Control1 week ago Market may open flat  Business Standard2 months ago IT stocks lead the gainers  Equitymaster.com6 days ago Pre-Market: Earning-driven rally  Smart Investor1 week ago
Money Control

See more drug price caps; max impact on Sanofi: Expert

W Also read: NPPA adding more drugs a retrograde step: Lupin Bigger brands were charging more for the same drug molecules. Infact now the government is likely to bring more formulations under the drug pricing purview. All medicines to cure ...
 Moneycontrol.com2 weeks ago NPPA adding more drugs a retrograde step: Lupin  Money Control2 weeks ago Interact with CNBC-TV18: Large pharma cos like DRL, Lupin, Ipca Labs good bet: ILFS  Money Control1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less